The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.30

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Males, 2006-2012
Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 97,136 69.4 69.0 69.8 89.7 88.8 90.6 75.6 75.2 76.1 59.0 58.2 59.7
1 Hodgkin Lymphoma 8,168 85.4 84.4 86.3 96.7 95.2 97.8 88.7 87.7 89.6 54.3 50.0 58.4
2 Non-Hodgkin lymphoma 86,731 68.3 67.9 68.8 88.0 86.9 89.0 74.1 73.6 74.6 59.6 58.9 60.4
2(a) Non-Hodgkin lymphoma, B-cell 79,652 68.8 68.3 69.2 88.5 87.2 89.7 75.1 74.5 75.6 60.2 59.4 61.0
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 4,284 68.6 67.0 70.2 87.9 86.4 89.3 38.5 35.3 41.7 19.3 14.0 25.2
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 71,668 68.9 68.4 69.4 90.5 87.9 92.5 76.4 75.9 77.0 60.6 59.7 61.3
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 18,803 77.4 76.4 78.3 - - - 85.5 84.4 86.5 70.9 69.4 72.4
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 16,158 81.0 79.9 82.0 - - - 88.7 87.5 89.8 75.0 73.3 76.5
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 67 48.5 30.9 64.0 - - - 61.6 34.5 80.3 40.5 20.4 59.8
2(a) 2.1.3. Mantle-cell lymphoma 2,578 55.5 52.8 58.1 - - - 67.6 64.2 70.9 43.9 40.0 47.8
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,598 81.9 78.2 84.9 - - - 88.4 84.5 91.4 77.4 72.0 81.9
2(a) 2.2.1. Lymphoplasmacytic lymphoma 683 77.9 72.2 82.6 - - - 84.0 77.3 88.8 73.4 65.0 80.1
2(a) 2.2.2. Waldenstrom macroglubulinemia 915 84.9 79.9 88.7 - - - 91.3 85.6 94.8 80.6 73.1 86.2
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 18,472 62.0 61.0 62.9 89.8 85.1 93.0 69.0 67.9 70.1 52.7 51.1 54.3
2(a) 2.3.1. DLBCL, NOSc 18,267 62.0 61.1 62.9 90.3 85.6 93.5 69.0 67.9 70.1 52.8 51.2 54.4
2(a) 2.3.2. Intravascular large B-cell lymphoma 27 39.2 16.8 61.1 - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma 50 23.4 11.6 37.7 - - - 22.6 10.4 37.7 - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 128 79.0 68.1 86.5 - - - 84.4 73.1 91.2 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 1,586 62.1 59.4 64.7 89.4 85.7 92.3 57.7 54.3 60.9 36.2 27.6 44.7
2(a) 2.5. Marginal-zone lymphoma (MZL) 4,353 89.6 87.7 91.2 100.0 - - 92.4 90.5 93.9 86.5 83.2 89.1
2(a) 2.5.1. Splenic MZL 378 88.5 81.2 93.0 - - - 83.4 74.7 89.4 89.9 80.5 94.9
2(a) 2.5.2. Extranodal MZL, MALTc type 2,561 93.8 91.3 95.6 100.0 - - 95.5 93.3 97.0 91.5 86.1 94.9
2(a) 2.5.3. Nodal MZL 1,414 82.0 78.4 85.0 - - - 88.0 84.0 91.1 76.4 70.3 81.3
2(a) 2.6. Follicular lymphoma 8,896 86.5 85.3 87.6 96.5 75.8 99.6 90.2 89.0 91.3 80.5 78.0 82.7
2(a) 2.7. Hairy-cell leukemia 1,224 93.1 90.1 95.3 - - - 96.5 93.8 98.0 83.7 74.4 89.8
2(a) 2.8. Plasma cell neoplasms 16,714 49.3 48.2 50.3 - - - 60.8 59.4 62.2 39.2 37.7 40.7
2(a) 2.8.1. Plasmacytoma 1,172 67.6 63.7 71.2 - - - 76.5 72.2 80.3 53.2 45.8 60.1
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 15,542 47.9 46.8 49.0 - - - 59.2 57.7 60.7 38.4 36.9 40.0
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,700 66.6 64.3 68.9 91.9 79.4 96.9 73.3 70.4 76.0 60.9 57.3 64.3
2(b) Non-Hodgkin lymphoma, T-cell 6,288 64.2 62.7 65.7 86.9 84.3 89.1 65.7 63.9 67.5 50.4 47.1 53.6
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 350 65.6 60.2 70.5 86.0 79.9 90.3 47.5 39.0 55.5 - - -
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 5,914 64.2 62.6 65.7 87.2 84.2 89.7 66.7 64.8 68.5 51.1 47.8 54.4
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,389 88.3 85.0 90.9 100.0 - - 90.9 87.7 93.3 81.8 73.1 87.9
2(b) 2.1.1. Mycosis fungoides 1,341 90.3 86.9 92.8 100.0 - - 91.9 88.8 94.2 85.7 76.4 91.5
2(b) 2.1.2. Sezary syndrome 48 31.3 13.7 50.8 - - - - - - 14.3 1.0 43.7
2(b) 2.2. Peripheral T-cell lymphoma 3,285 56.3 54.2 58.4 82.7 75.9 87.8 62.3 59.6 64.8 43.2 39.3 47.0
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 1,176 38.6 35.1 42.2 72.0 49.9 85.6 44.6 40.0 49.1 28.5 23.1 34.2
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 396 40.2 34.1 46.1 - - - 49.2 40.5 57.3 31.6 23.3 40.2
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 29 83.2 62.5 93.1 - - - - - - - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 701 57.1 52.8 61.2 85.7 77.0 91.3 60.7 55.4 65.6 29.5 20.5 39.0
2(b) 2.2.5. Hepatosplenic T-cell lymphoma 36 26.5 12.1 43.4 - - - 34.1 16.1 53.0 - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 29 19.3 6.0 38.1 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 622 83.7 79.0 87.5 - - - 87.2 81.9 91.1 75.8 67.1 82.4
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 296 88.8 81.5 93.3 - - - 95.1 89.5 97.8 77.1 59.4 87.8
2(b) 2.3. Adult T-cell leukemia/lymphoma 836 66.5 62.4 70.2 88.4 84.6 91.3 44.1 36.9 51.1 5.0 0.4 19.9
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 280 42.7 36.0 49.3 - - - 41.0 33.5 48.4 40.4 24.0 56.2
2(b) 2.5. T-cell large granular lymphocytic leukemia 39 59.0 39.3 74.2 - - - - - - - - -
2(b) 2.6. Prolymphocytic leukemia, T-cell 85 17.7 8.3 29.9 - - - 21.4 8.8 37.5 14.2 3.2 33.0
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell - - - - - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 791 58.0 54.0 61.7 84.4 78.4 88.8 55.8 49.7 61.5 39.9 32.7 47.1
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 340 62.9 57.3 67.9 84.0 78.0 88.5 38.5 28.0 48.9 21.3 10.5 34.6
2(c) 2. Prolymphocytic leukemia, unknown lineage - - - - - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 433 54.3 48.6 59.6 - - - 62.9 55.6 69.4 43.8 35.2 52.1
2(*) 1. Total precursor lymphoma/leukemiad 4,974 68.1 66.6 69.5 87.6 86.2 88.8 39.7 36.9 42.6 18.9 14.2 24.1
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 71 77.1 60.9 87.3 - - - 81.1 64.9 90.3 - - -
4 Lymphoid neoplasm, NOSc 2,166 49.0 46.3 51.6 84.6 69.5 92.6 58.1 54.5 61.6 39.7 35.7 43.7

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.